MedPath

Randomized Control Trial To Determine The Use And Safety of Hypertonic Saline Gargling In Acute Upper Respiratory Tract Infections in Childre

Phase 4
Conditions
Health Condition 1: J00- Acute nasopharyngitis [common cold]
Registration Number
CTRI/2023/11/059420
Lead Sponsor
Post Graduate Institute of Medical Education & Research, Chandigarh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children from 4-12 years of age with upper respiratory tract infection (as defined below), who are capable of gargling, to be determined by demonstration in the OPD.

Definition of URTI:

Presence of at least two respiratory symptoms such as nasal congestion (runny nose, stuffy nose), cough, sore throat OR a respiratory symptom plus at least one systemic symptom (Low energy/tired, muscle aches/pains, headache, fever =38°C) ?.

Exclusion Criteria

1.Children who are unable to gargle.

2.SARS-CoV2 PCR positive children

3.Children with:

a.Known pre-existing chronic respiratory disease viz. cystic fibrosis, pulmonary or extrapulmonary tuberculosis, bronchiectasis.

b.Allergic rhinitis

c.Known aero-digestive disorders such as gastro-esophageal reflux disease.

d.Immunosuppression for any reason.

e.Known primary or secondary immune deficiency.

4.Children taking part in any other trials.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time for resolution of URTI.Timepoint: This will be defined as the time taken (in days) for resolution of all symptoms of the URI episode from the time of randomization <br/ ><br> <br/ ><br>Severity of illness will be assessed by the WURSSK score that will be scored by the parents/children on a daily basis. <br/ ><br> <br/ ><br>Score will be recorded at enrollment upto the time of resolution or 14 days whichever is earlier <br/ ><br> <br/ ><br>Resolution is defined as the WURSSK score being 0 <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Discontinuation of study medicationsTimepoint: subjective as per reasons stated by patient within 14 days or resolution of symptoms;Need for contacting healthcare professionalTimepoint: Number of times contacted within 14 days or resolution, whichever earlier;Number of days lost from schoolTimepoint: Within 14 days or upto resolution of symptoms;Number of days lost from work for parentsTimepoint: days lost within 14 days or upto resolution of symptoms of child;Parental assessment of severityTimepoint: Based on WURSSK score, 14 days or resolution whichever earlier;Perceived adverse eventsTimepoint: Number & type of adverse events within 14 days or resolution, whichever earlier;Resolution of symptomsTimepoint: 14 days or resolution whichever earlier
© Copyright 2025. All Rights Reserved by MedPath